All Pathways
EndocrinologyEmergency

Severe Hypoglycemia Management

Severe Hypoglycemia Management: Suspected Hypoglycemia → Classify Hypoglycemia Level → Is Patient Conscious & Able to Swallow? → Oral Glucose Treatment ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Hypoglycemia

    Patient with symptoms or confirmed low glucose

    1. Decision

      Classify Hypoglycemia Level

      ADA Classification

      • Level 1: Glucose 54-70 mg/dL (3.0-3.9 mmol/L) - Alert value
      • Level 2: Glucose <54 mg/dL (<3.0 mmol/L) - Clinically significant
      • Level 3: Severe - Altered mental status, requires assistance
      1. Decision

        Is Patient Conscious & Able to Swallow?

        Assess mental status and ability to take PO

        1. Action

          Oral Glucose Treatment

          Rule of 15

          • Give 15-20g fast-acting carbohydrate:
          • - Glucose tablets (4 tabs = 16g)
          • - 4 oz (120 mL) juice or regular soda
          • - 1 tablespoon sugar or honey
          • Recheck glucose in 15 minutes
          • Repeat if still <70 mg/dL
          1. Action

            Recheck Glucose in 15 Minutes

            Assess response to treatment

            1. Decision

              Glucose >70 mg/dL & Symptoms Resolved?

              Evaluate treatment response

              1. Action

                Post-Treatment Care

                Prevent recurrence

                • Give substantial snack or meal if not eating soon
                • Include protein and complex carbohydrates
                • Review cause of hypoglycemia
                • Adjust diabetes medications if needed
                • Education on hypoglycemia prevention
                1. Action

                  Evaluate Underlying Cause

                  Identify precipitant to prevent recurrence

                  • Missed meal or reduced food intake
                  • Excess insulin or secretagogue dose
                  • Increased physical activity
                  • Alcohol consumption
                  • Renal or hepatic impairment
                  • Adrenal insufficiency (consider if recurrent)
                  1. Outcome

                    Hypoglycemia Resolved

                    Ensure follow-up and medication adjustment

                  2. Warning

                    Hospital Admission

                    For refractory, sulfonylurea, or unclear cause

              2. Action

                Repeat Treatment

                Glucose still low

                • Repeat glucose treatment
                • Consider continuous D10W infusion
                • Evaluate for sulfonylurea or long-acting insulin
                • May need prolonged monitoring (12-24h)
              3. Warning

                ⚠️ Sulfonylurea Warning

                Extended monitoring required

                • Sulfonylurea-induced hypoglycemia may recur
                • Monitor glucose every 1-2 hours for 12-24h
                • Consider octreotide 50 mcg SubQ q6-8h
                • Hospital admission often required
        2. Decision

          IV Access Available?

          Determine route for treatment

          1. Action

            IV Dextrose

            Preferred if IV access present

            • D50W: 25-50 mL (12.5-25g dextrose) IV push
            • OR D10W: 100-250 mL if peripheral line
            • Effect within 1-3 minutes
            • May repeat in 15 minutes if needed
            • Follow with D10W infusion if recurrent
          2. Action

            Glucagon Administration

            When IV access not available

            • Intranasal: 3 mg single spray (preferred)
            • IM/SubQ: 1 mg injection
            • Auto-injector: Per device instructions
            • Onset: 10-15 minutes
            • Turn patient on side (aspiration risk)
            • Less effective if glycogen depleted

Guideline Source

ADA Standards of Care in Diabetes - Glycemic Goals and Hypoglycemia 2025

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address neonatal hypoglycemia
  • Sulfonylurea-induced hypoglycemia may require prolonged monitoring
  • Does not cover insulinoma workup
  • Requires access to glucagon preparations

Contraindicated Populations

neonatal

Applicable Regions

USEUUK

EU: Check local glucagon formulation availability

US: Intranasal and auto-injector glucagon widely available

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Severe Hypoglycemia Management?

The Severe Hypoglycemia Management is a emergency clinical algorithm for Endocrinology. It provides a structured decision tree to guide clinical decision-making, based on ADA Standards of Care in Diabetes - Glycemic Goals and Hypoglycemia 2025.

What guideline is the Severe Hypoglycemia Management based on?

This algorithm is based on ADA Standards of Care in Diabetes - Glycemic Goals and Hypoglycemia 2025 (DOI: 10.2337/dc25-S006).

What are the limitations of the Severe Hypoglycemia Management?

Known limitations include: Does not address neonatal hypoglycemia; Sulfonylurea-induced hypoglycemia may require prolonged monitoring; Does not cover insulinoma workup; Requires access to glucagon preparations. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Severe Hypoglycemia Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free